Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Biopsy × 30 days × Clear all

Sponsor

Conditions

Neoplasm Metastasis 30 Leukemia, Myeloid, Acute 21 Multiple Myeloma 18 Lymphoma 13 Colorectal Neoplasms 13 Triple Negative Breast Neoplasms 10 Melanoma 10 Lung Neoplasms 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Myeloproliferative Disorders 8 Myelodysplastic Syndromes 8 Carcinoma, Non-Small-Cell Lung 8 Burkitt Lymphoma 7 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 6 Myelodysplastic-Myeloproliferative Diseases 6 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Endometrial Neoplasms 6 Breast Neoplasms 6 Sarcoma 5 Neuroblastoma 5 Mouth Neoplasms 5 Lymphoma, Non-Hodgkin 5 Glioma 5 Fallopian Tube Neoplasms 5 Carcinoma, Renal Cell 5 Urinary Bladder Neoplasms 4 Stomach Neoplasms 4

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡